Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation

被引:71
作者
Sundaram, V
Hanna, AN
Koneru, L
Newman, HAI
Falko, JM
机构
[1] OHIO STATE UNIV, DEPT INTERNAL MED, COLUMBUS, OH 43210 USA
[2] OHIO STATE UNIV, DEPT PATHOL, COLUMBUS, OH 43210 USA
关键词
D O I
10.1210/jcem.82.10.4315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypothyroidism is frequently associated with hypercholesterolemia and an increased risk for atherosclerosis, whereas hyperthyroidism is known to precipitate angina or myocardial infarction in patients with underlying coronary heart disease. We have shown previously that L-T-4 functions as an antioxidant in vitro and inhibits low density lipoprotein (LDL) oxidation in a dose-dependent fashion. The present study was designed to evaluate the changes in LDL oxidation in subjects with hypothyroidism and hyperthyroidism. Fasting blood samples for LDL oxidation analyses, lipoprotein determinations, and thyroid function tests were collected at baseline and after the patients were rendered euthyroid. The lag phase (mean +/- SEM hours) of the Cu+2-catalyzed LDL oxidation in the hypothyroid state and the subsequent euthyroid states were 4 +/- 0.0.65 and 14 +/- 0.68 h, respectively (P < 0.05). The lag phase during the hyperthyroid phase was 6 +/- 0.55 h, and that during the euthyroid phase was 12 +/- 0.66 h (P < 0.05). The total and LDL cholesterol levels were higher in hypothyroidism than in euthyroidism and were lower in hyperthyroidism than in the euthyroid state. We conclude that LDL has more susceptibility to oxidation in both the hypothyroid and hyperthyroid states. Thus, the enhanced LDL oxidation may play a role in the cardiac disease process in both hypothyroidism and hyperthyroidism.
引用
收藏
页码:3421 / 3424
页数:4
相关论文
共 22 条
[1]  
ABRAMS JJ, 1981, J LIPID RES, V22, P323
[2]   LDL/HDL-CHANGES IN SUBCLINICAL HYPOTHYROIDISM - POSSIBLE RISK-FACTORS FOR CORONARY HEART-DISEASE [J].
ALTHAUS, BU ;
STAUB, JJ ;
RYFFDELECHE, A ;
OBERHANSLI, A ;
STAHELIN, HB .
CLINICAL ENDOCRINOLOGY, 1988, 28 (02) :157-163
[3]   LOCALIZATION OF THE THYROXINE BINDING-SITES IN APOLIPOPROTEIN-B-100 OF HUMAN LOW-DENSITY LIPOPROTEINS [J].
BENVENGA, S ;
CAHNMANN, HJ ;
ROBBINS, J .
ENDOCRINOLOGY, 1990, 127 (05) :2241-2246
[4]   BINDING OF THYROID-HORMONES TO HUMAN-PLASMA LIPOPROTEINS [J].
BENVENGA, S ;
GREGG, RE ;
ROBBINS, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :6-16
[5]   ENHANCEMENT OF THYROXINE ENTRY INTO LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR-COMPETENT FIBROBLASTS BY LDL - AN ADDITIONAL MODE OF ENTRY OF THYROXINE INTO CELLS [J].
BENVENGA, S ;
ROBBINS, J .
ENDOCRINOLOGY, 1990, 126 (02) :933-941
[6]   DECREASED HDL CHOLESTEROL IN SUBCLINICAL HYPOTHYROIDISM - THE EFFECT OF L-THYROXINE THERAPY [J].
CARON, P ;
CALAZEL, C ;
PARRA, HJ ;
HOFF, M ;
LOUVET, JP .
CLINICAL ENDOCRINOLOGY, 1990, 33 (04) :519-523
[7]   REGULATORY ROLE OF TRIIODOTHYRONINE IN THE DEGRADATION OF LOW-DENSITY LIPOPROTEIN BY CULTURED HUMAN-SKIN FIBROBLASTS [J].
CHAIT, A ;
BIERMAN, EL ;
ALBERS, JJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 48 (05) :887-889
[8]   SUPEROXIDE RADICAL GENERATION, NADPH OXIDASE ACTIVITY, AND CYTOCHROME-P-450 CONTENT OF RAT-LIVER MICROSOMAL FRACTIONS IN AN EXPERIMENTAL HYPERTHYROID STATE - RELATION TO LIPID-PEROXIDATION [J].
FERNANDEZ, V ;
BARRIENTOS, X ;
KIPREOS, K ;
VALENZUELA, A ;
VIDELA, LA .
ENDOCRINOLOGY, 1985, 117 (02) :496-501
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   INHIBITION OF LOW-DENSITY-LIPOPROTEIN OXIDATION BY THYRONINES AND PROBUCOL [J].
HANNA, AN ;
FELLER, DR ;
WITIAK, DT ;
NEWMAN, HAI .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (03) :753-762